26 November 2007
Rare case of Cefotaxime induced leukocytoclastic vasculitis in alcoholic cirrhosis patient
Erkan Cure , Altug Senol , Cem Kockar , Abdulkadir Basturk , Yildiran SongurCase Rep Clin Pract Rev 2007; 8:309-312 :: ID: 559627
Abstract
Background: Vasculitis is simply infl ammation directed at blood vessels identifi ed by histological examination. Pathogenesis of leukocytoclastic vasculitis (LCV) most frequently includes infection, immunological agents and drugs. A third-generation cephalosporin cefotaxime induced LCV has not been reported before in the literature.
Case Report: A 51 years old male patient admitted for decompensated cirrhosis to our gastroenterology clinic with complaints of abdominal distention and pretibial edema. He had low-grade fever so cefotaxime treatment was administered three times 1 g in a day intravenously. In seventh day of antibiotic therapy, skin rashes were occurred on lower extremities. After cefotaxime therapy was stopped skin rashes were disappeared on forth day. According to the Naranjo probability scale, the vasculitis experienced by our patient was probably due to cefotaxime.
Conclusions: Drug induced LCV usually occurs after seventh day of treatment. Lesions usually disappear in a little time after drugs are stopped. In our case skin rashes were disappeared on forth day after cefotaxime therapy has been discontinued. So we thought cefotaxime caused to LCV lesions.
Keywords: leukocytoclastic vasculitis, Cefotaxime, drug induced vasculitis, Alcoholic Cirrhosis
952
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953173
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953192
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.952818
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953608
Most Viewed Current Articles
07 Dec 2021 : Case report
22,364,578
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
174,245
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
119,744
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
64,648
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






